Roche’s Virtual Ophthalmology Investor Event
Roche has hosted a virtual event on Tuesday, 21 October 2025
| Agenda | |
|---|---|
| Introduction | Bruno Eschli, Head of Investor Relations |
| Ophthalmology Franchise Update | Nilesh Mehta, Franchise Head Ophthalmology, Global Product Strategy |
| Ph III (SANDCAT/MEERKAT) vamikibart in UME | Dr. Nisha Acharya, Professor and Director, Ocular Inflammatory Disease and Uveitis Clinic, University of California, San Francisco |
| Ph III (SatraGo-1/SatraGo-2) satralizumab in TED | César A. Briceño, MD, Associate Professor of Ophthalmology, Surgery, and Dermatology, Perelman School of Medicine, University of Pennsylvania |
| Q&A |